<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02817139</url>
  </required_header>
  <id_info>
    <org_study_id>migraine</org_study_id>
    <nct_id>NCT02817139</nct_id>
  </id_info>
  <brief_title>Transcranial Direct Current Simulation in Chronic Migraine</brief_title>
  <official_title>Transcranial Direct Current Simulation Over Primary Motor vs Prefrontal Cortex in Chronic Migraine: a Pilot Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Paraíba</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Paraíba</source>
  <brief_summary>
    <textblock>
      This study is a pilot, double-blind, placebo-controlled, randomized trial aiming to compare
      the effects of transcranial direct current stimulation in Chronic Migraine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The patients will be randomized into 1 of 3 groups: active tDCS over primary motor cortex,
      active tDCS over prefrontal cortex, sham tDCS. Each group will receive treatment for 20
      minutes a day, 3 days a week for 4 weeks.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in quality of life associate to migraine assessed on the Headache Impact Test-6 (HIT-6)</measure>
    <time_frame>Baseline (week 1) and Endpoint (week 4)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in pain assessed on the Visual Analogue Scale (VAS)</measure>
    <time_frame>Baseline (week 1) and Endpoint (week 4)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life assessed on the Medical Outcomes Study 36 - Item Short - Form Health Survey(SF-36)</measure>
    <time_frame>Baseline (week 1) and and Endpoint (week 4)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Side Effects Questionnaire</measure>
    <time_frame>From date of first neurostimulation until the date of last neurostimulation, , assessed up to 1 month</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Migraine Disorders</condition>
  <arm_group>
    <arm_group_label>active tDCS over primary motor cortex</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Duration: 20 minutes; Intensity: 2 mA; Placement: left primary motor cortex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>active tDCS over prefrontal cortex</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Duration: 20 minutes; Intensity: 2 mA; Placement: left prefrontal cortex.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS over primary motor cortex</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Duration: 20 minutes; The procedure is the same as for active tDCS, but the in the placebo tDCS the stimulation is non-active / sham; Placement: left primary motor cortex.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TDCS</intervention_name>
    <arm_group_label>active tDCS over primary motor cortex</arm_group_label>
    <arm_group_label>active tDCS over prefrontal cortex</arm_group_label>
    <arm_group_label>sham tDCS over primary motor cortex</arm_group_label>
    <other_name>Transcranial Direct Current Stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with a clinical diagnosis of chronic migraine according to the International
             Classification of Headaches Disorders (ICHD-3 beta) of the International Headache
             Society, with an established headache history occurring on 15 or more days per
             month—however, for at least 1 year, instead of only 3 months, as defined in the
             International Headache Society (IHS) guidelines.

        Exclusion Criteria:

          -  headache attributable to some pathological condition, associated neurologic or
             neuropsychiatric disease, use of central nervous system modulating drugs, pregnancy,
             metallic head implants, and use of a cardiac pacemaker.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Suellen Andrade</name>
      <address>
        <city>João Pessoa</city>
        <state>PB</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suellen Andrade</last_name>
      <email>suellenandrade@gmail.com</email>
    </contact>
    <contact_backup>
      <email>suellenandrade@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2016</study_first_submitted>
  <study_first_submitted_qc>June 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2016</study_first_posted>
  <last_update_submitted>June 25, 2016</last_update_submitted>
  <last_update_submitted_qc>June 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Paraíba</investigator_affiliation>
    <investigator_full_name>Suellen Marinho Andrade</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

